Format

Send to

Choose Destination
PLoS One. 2017 Jan 3;12(1):e0169114. doi: 10.1371/journal.pone.0169114. eCollection 2017.

Blue-Light Filtering Spectacle Lenses: Optical and Clinical Performances.

Author information

1
School of Optometry, The Hong Kong Polytechnic University, Hung Hom, Kowloon, Hong Kong SAR.
2
School of Optometry, University of California, Berkeley, California, United States of America.

Abstract

PURPOSES:

To evaluate the optical performance of blue-light filtering spectacle lenses and investigate whether a reduction in blue light transmission affects visual performance and sleep quality.

METHODS:

Experiment 1: The relative changes in phototoxicity, scotopic sensitivity, and melatonin suppression of five blue-light filtering plano spectacle lenses were calculated based on their spectral transmittances measured by a spectrophotometer. Experiment 2: A pseudo-randomized controlled study was conducted to evaluate the clinical performance of two blue-light filtering spectacle lenses (BF: blue-filtering anti-reflection coating; BT: brown-tinted) with a regular clear lens (AR) serving as a control. A total of eighty computer users were recruited from two age cohorts (young adults: 18-30 yrs, middle-aged adults: 40-55 yrs). Contrast sensitivity under standard and glare conditions, and colour discrimination were measured using standard clinical tests. After one month of lens wear, subjective ratings of lens performance were collected by questionnaire.

RESULTS:

All tested blue-light filtering spectacle lenses theoretically reduced the calculated phototoxicity by 10.6% to 23.6%. Although use of the blue-light filters also decreased scotopic sensitivity by 2.4% to 9.6%, and melatonin suppression by 5.8% to 15.0%, over 70% of the participants could not detect these optical changes. Our clinical tests revealed no significant decrease in contrast sensitivity either with (95% confidence intervals [CI]: AR-BT [-0.05, 0.05]; AR-BF [-0.05, 0.06]; BT-BF [-0.06, 0.06]) or without glare (95% CI: AR-BT [-0.01, 0.03]; AR-BF [-0.01, 0.03]; BT-BF [-0.02, 0.02]) and colour discrimination (95% CI: AR-BT [-9.07, 1.02]; AR-BF [-7.06, 4.46]; BT-BF [-3.12, 8.57]).

CONCLUSION:

Blue-light filtering spectacle lenses can partially filter high-energy short-wavelength light without substantially degrading visual performance and sleep quality. These lenses may serve as a supplementary option for protecting the retina from potential blue-light hazard.

TRIAL REGISTRATION:

ClinicalTrials.gov NCT02821403.

PMID:
28045969
PMCID:
PMC5207664
DOI:
10.1371/journal.pone.0169114
[Indexed for MEDLINE]
Free PMC Article

Conflict of interest statement

Financial support for research: Salary for a research assistant, blue-light filtering spectacle lenses. Employment: The research assistant was employed by Hong Kong PolyU; None of the authors/ research personal was employed by the company. Consultancy: Part of the funding was charged as consulting fee Stocks, shares or ownership of company: None. Patents: None. Products in development: None. Marketed products: None. Royalties: None. We confirm that this does not alter our adherence to PLOS ONE policies on sharing data and materials.

Supplemental Content

Full text links

Icon for Public Library of Science Icon for PubMed Central
Loading ...
Support Center